Endothelial cell survival and apoptosis in the tumor vasculature

Apoptosis

Volumn 5, Issue 4, 2000, Pages 323-328

  Liu, W ^a   Ahmad, S A ^a   Reinmuth, N ^a   Shaheen, R M ^a   Jung, Y D ^a   Fan, F ^a   Ellis, L M ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Angiogenesis; Angiopoietins; Apoptosis; Integrins; Vascular endothelial growth factor

Indexed keywords

ANGIOPOIETIN 1; PROTEIN BCL 2; TYROSINE KINASE RECEPTOR; VASCULOTROPIN;

APOPTOSIS; ARTICLE; CELL INTERACTION; CELL PROLIFERATION; CELL SURVIVAL; ENDOTHELIUM CELL; HUMAN; METASTASIS; NEOVASCULARIZATION (PATHOLOGY); PERICYTE; PRIORITY JOURNAL; TUMOR GROWTH;

ANGIOPOIETIN-1; ANIMALS; APOPTOSIS; CELL SURVIVAL; ENDOTHELIAL GROWTH FACTORS; ENDOTHELIUM, VASCULAR; HUMANS; INTEGRINS; LYMPHOKINES; MEMBRANE GLYCOPROTEINS; MODELS, BIOLOGICAL; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; PERICYTES; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTOR, TIE-2; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0033761908     PISSN: 13608185     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1009679307513     Document Type: Article

References (60)

1. Tumor angiogenesis: Therapeutic implications
2. Angiogenesis in cancer, vascular, rheumatoid and other disease
3. Angiogenesis: Mechanistic insights, neovascular diseases, and therapeutic prospects
4. Vascular permeability factor, an endothelial cell mitogen related to PDGF
5. Significance of vessel count and vascular endothelial growth factor and its receptor (KDR) in intestinal-type gastric cancer
6. Tumor angiogenesis is an independent prognostic indicator in primary breast carcinoma
7. Relation of neovascularisation to metastasis of non-small-cell lung cancer
8. Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma
9. Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis, and proliferation of human colon cancer
10. Vessel counts and VEGF expression as prognostic factors in node-negative colon cancer
11. Vascular endothelial growth factor is a secreted angiogenic mitogen
12. Isolation and characterization of a newly identified endothelial cell mitogen produced by AtT-20 cells
13. Vascular permeability factor (vascular endothelial growth factor) gene is expressed differentially in normal tissues, macrophages, and tumors
14. The vascular endothelial growth factor family: Identification of a fourth molecular species and characterization of alternative splicing of RNA
15. The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing
16. Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis
17. In vivo effects of vascular endothelial growth factor on the chicken chorioallantoic membrane
18. Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity
19. Conditional switching of vascular endothelial growth factor (VEGF) expression in tumors: Induction of endothelial cell shedding and regression of hemangioblastoma-like vessels by VEGF withdrawal
20. Vascular endothelial growth factor induces expression of the antiapoptotic proteins Bcl-2 and A1 in vascular endothelial cells
21. Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3'-kinase/Akt signal transduction pathway. Requirement for Flk- 1/KDR activation
22. Antiangiogenic therapy targeting the tyrosine kinase receptor for vascular endothelial growth factor receptor inhibits the growth of colon cancer liver metastasis and induces tumor and endothelial cell apoptosis
23. Vascular endothelial growth factor is an in vivo survival factor for tumor endothelium in a murine model of colorectal liver metastases
24. VEGF prevents apoptosis of human microvascular endothelial cells via opposing effects on MAPK/ERK and SAPK/JNK signaling
25. Vascular permeability factor/vascular endothelial growth factor inhibits anchorage-disruption-induced apoptosis in microvessel endothelial cells by inducing scaffold formation
26. The inhibitors of apoptosis (IAPs) and their emerging role in cancer
27. IAP family proteins - Suppressors of apoptosis
28. Marked induction of the IAP family antiapoptotic proteins survivin and XIAP by VEGF in vascular endothelial cells
29. Vascular endothelial genes that are responsive to tumor necrosis factor-alpha in vitro are expressed in atherosclerotic lesions, including inhibitor of apoptosis protein-1, stannin, and two novel genes
30. Control of apoptosis during angiogenesis by survivin expression in endothelial cells
31. Targetting VEGF in anti-angiogenic and antitumour therapy: Where are we now?
32. Antiagiogenic strategies and agents in clinical trials
33. Role of endothelial cell survival and death signals in angiogenesis
34. SU5416 is a potent and selective inhibitor of the vascular endothelial growth factor receptor (Flk-1/KDR) that inhibits tyrosine kinase catalysis, tumor vascularization, and growth of multiple tumor types
35. A novel endothelial cell surface receptor tyrosine kinase with extracellular epidermal growth factor homology domains
36. Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis
37. Angiopoietin-1 is an apoptosis survival factor for endothelial cells
38. Direct actions of angiopoietin-1 on human endothelium: Evidence for network stabilization, cell survival, and interaction with other angiogenic growth factors
39. Angiopoietin-1 inhibits endothelial cell apoptosis via the Akt/survivin pathway
40. Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF
41. Inhibition of tumor angiogenesis using a soluble receptor establishes a role for Tie2 in pathologic vascular growth
42. Antiangiogenic gene therapy targeting the endothelium-specific receptor tyrosine kinase Tie2
43. Integrins: Versatility, modulation, and signaling in cell adhesion
44. The extracellular matrix as a cell survival factor
45. Integrin alpha v beta 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels
46. Disruption of epithelial cell-matrix interactions induces apoptosis
47. Antiintegrin alpha v beta 3 blocks human breast cancer growth and angiogenesis in human skin
48. Suppression of p53 activity and p21WAF1/CIP1 expression by vascular cell integrin alpha Vbeta3 during angiogenesis
49. Integrin alpha(v)beta3 promotes M21 melanoma growth in human skin by regulating tumor cell survival
50. The role of alphav integrins during angiogenesis: Insights into potential mechanisms of action and clinical development
51. A plasticity window for blood vessel remodelling is defined by pericyte coverage of the preformed endothelial network and is regulated by PDGF-B and VEGF
52. Brain macrophages: On the role of pericytes and perivascular cells
53. Pericytes in the microvasculature
54. Pericyte involvement in capillary sprouting during angiogenesis in situ
55. Rat aortic smooth muscle cells become pericytes during angiogenesis in vitro
56. Capillary growth: A two-cell system
57. PDGF, TGF-beta, and heterotypic cell-cell interactions mediate endothelial cell-induced recruitment of 10T1/2 cells and their differentiation to a smooth muscle fate
58. Pericyte loss and microaneurysm formation in PDGF-B-deficient mice
59. Role of PDGF-B and PDGFR-beta in recruitment of vascular smooth muscle cells and pericytes during embryonic blood vessel formation in the mouse
60. Heterogeneity of angiogenesis and blood vessel maturation in human tumors: Implications for antiangiogenic tumor therapies